Search details
1.
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet
; 402(10407): 1043-1051, 2023 09 23.
Article
in English
| MEDLINE | ID: mdl-37524096
2.
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
Mod Pathol
; 37(2): 100404, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-38104891
3.
Real-time estimation of nephron activity with a linear measurement system (RENAL-MS) predicts postoperative estimated glomerular filtration rate.
BJU Int
; 133(2): 206-213, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37667554
4.
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.
BJU Int
; 133(2): 169-178, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37589200
5.
Pathological and Clinical Outcomes in a Large Surveillance and Intervention Cohort of Radiographically Cystic Renal Masses.
J Urol
; 209(4): 686-693, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36630588
6.
Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice.
J Urol
; 210(3): 438-445, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37378576
7.
Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium.
J Urol
; 210(5): 750-762, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37579345
8.
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis.
J Urol
; 208(1): 71-79, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35212574
9.
Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry.
J Urol
; 208(2): 268-276, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35377778
10.
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.
BJU Int
; 129(6): 718-722, 2022 06.
Article
in English
| MEDLINE | ID: mdl-34480522
11.
Safety of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and malignant ureteric obstruction.
BJU Int
; 129(3): 364-372, 2022 03.
Article
in English
| MEDLINE | ID: mdl-33780097
12.
Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine.
J Natl Compr Canc Netw
; 20(2): 160-166, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35130494
13.
A Critical Appraisal of the American College of Surgeons Medically Necessary, Time Sensitive Procedures (MeNTS) Scoring System, Urology Consensus Recommendations and Individual Surgeon Case Prioritization for Resumption of Elective Urological Surgery During the COVID-19 Pandemic.
J Urol
; 205(1): 241-247, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32716742
14.
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II.
J Urol
; 206(2): 209-218, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34115531
15.
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I.
J Urol
; 206(2): 199-208, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34115547
16.
Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial.
J Urol
; 205(6): 1605-1611, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33535799
17.
Pathological characteristics of the large renal mass: potential implication for clinical role of renal biopsy.
Can J Urol
; 28(2): 10620-10624, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33872561
18.
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma.
Br J Cancer
; 123(12): 1749-1756, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32968206
19.
Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.
J Urol
; 203(4): 684-689, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31596672
20.
Sporadic Angiomyolipomas Growth Kinetics While on Everolimus: Results of a Phase II Trial.
J Urol
; 204(3): 531-537, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32250730